Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

NCT02518945 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Dapagliflozin
DRUG: Insulin
DRUG: Liraglutide
DRUG: Dapagliflozin placebo

Sponsor

University at Buffalo